ARTICLE | Clinical News
Nasal CO2: Phase II started
February 29, 2016 8:00 AM UTC
Capnia began a single-blind, U.S. Phase II trial to evaluate nasal CO2 in about 50 patients. Patients will receive 6 doses of nasal CO2 or placebo, with each dose given over 10 seconds, in the nostril...